For this blog dedicated to #AHA20, I decided to put together a list of majority of American Heart Association (AHA) late-breaking study presentations at the 2020 Virtual AHA meeting from Day 1 to Day 3. So far, the late-breaking studies at AHA have covered a wide range of topics from heart failure, cardiovascular prevention focusing … Read more
Curious about what a Fellow of the American Heart Association (FAHA) was, I attended the “Journey to becoming FAHA” panel discussion this afternoon to learn more from Dr. Annet Kirabo (Vanderbilt University), Dr. Nasrien Ibrahim (Massachusetts General Hospital), Dr. Swapnil Hiremath (Ottawa Hospital Research Institute), and Dr. Antonio Cabrera (University of Utah). Collectively, this panel … Read more
As an interventional cardiologist who’s passionate about reducing the disparities in diagnosis and management in women with cardiovascular disease, I was captivated by the late-breaking science that took the main arena for Current Challenges in Coronary and Valve Disease at Scientific Sessions 2020. The Coronary OCT and Cardiac MRI (CMR) to Determine Underlying Cause of … Read more
It was another exciting day of virtual sessions at #AHA20, led by intriguing findings from a few late-breaking trials! First, the STRENGTH and OMEMI trials added nuance to ongoing discussions about the cardiovascular benefits of fish oils and cardiovascular risk reduction. The REDUCE-IT trial, published in the New England Journal of Medicine (NEJM) in … Read more
On Saturday, November 14, 2020 there was an interesting session evaluating new data that impacts the care of patients with lower extremity peripheral arterial disease. For those of us involved in the daily care of these patients, we welcome new insights to help improve outcomes in this high risk patient population. First, Dr. Mary … Read more
In today’s climate, industries often talk about the new buzz word of this era, Big data. In this case, Big data refers to data on the macro scale (mostly unorganized and unstructured). The utilization of Big data has tremendous potential for various industries, healthcare included. Facebook, Amazon, Netflix, for example, incorporate big data for their … Read more
I was overwhelmed when I attended Scientific Sessions for the first time last year. There were thousands of participants and dozens of sessions occurring simultaneously in a very large convention center. It was challenging to try to attend all of the sessions that I was interested in. I was frequently disoriented in the large convention … Read more
What an end to the weekend! As Day 3 of AHA 2020 continues, there is already much to digest and discuss. From Late-Breaking Trials to specific programming for Fellows in Training and Early Career individuals, there was something for us all. My time was spent tuning in to informative discussions from leaders in the advanced … Read more
AHA20 virtual meeting has been packed by so many amazing sessions, covering all aspects of cardiovascular disease from basic science to clinical outcomes. I wanted to share some of the sessions “not to miss sessions” at AHA20 virtual meeting!! Opening Session Dr. Braunwald and Dr. Wenger, two of the legends in cardiology, took us back … Read more
“Coronary Optical Coherence Tomography (OCT) and Cardiac Magnetic Resonance (CMR) Imaging to Determine Underlying Causes of MINOCA in Women” was presented on day 2 of AHA by Dr. Harmony R. Reynolds, MD during the late-breaking trial session. The trial is also simultaneously published in Circulation(1). MINOCA (Myocardial Infarction with Nonobstructive Coronary Arteries) is quite a … Read more